Clinical Outcomes in Patients with Renal Cell Carcinoma Metastases to the Choroid Plexus

被引:8
|
作者
Crisman, Celina M. [1 ]
Patel, Ankur R. [2 ,3 ]
Winston, Graham [4 ]
Brennan, Cameron W. [2 ,3 ]
Tabar, Viviane [2 ,3 ]
Moss, Nelson S. [2 ,3 ]
机构
[1] UMass Mem Med Ctr, Dept Neurosurg, Worcester, MA USA
[2] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, 1275 York Ave, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Brain Metastasis Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Weill Cornell Med Coll, New York, NY USA
基金
美国国家卫生研究院;
关键词
Choroid plexus; Intraventricular metastasis; Renal cell carcinoma; Stereotactic body radiotherapy; Stereotactic radiosurgery; BRAIN METASTASES; PROGNOSTIC-FACTORS; SURVIVAL; RADIOSURGERY; THERAPY;
D O I
10.1016/j.wneu.2020.03.125
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: Intraventricular metastatic brain tumors account for a small, but challenging, fraction of metastatic brain tumors (0.9%-4.5%). Metastases from renal cell carcinoma (RCC) account for a large portion of these intraventricular tumors. Although patient outcomes have been assumed to be poor, these have not been reported in a modern series with a multimodality treatment paradigm of radiotherapy (RT), resection, and cerebrospinal fluid (CSF) diversion. We have presented the first case series of patients with intraventricular metastatic tumors from RCC. METHODS: We performed a single-institution retrospective review of patients with intraventricular RCC metastases treated from January 2003 to January 2019. Volumetric analysis was used to delineate the tumor size and the Kaplan-Meier method to evaluate the survival data. RESULTS: A total of 22 intraventricular RCC metastases were identified in 19 patients with 61.3 patient-years of follow-up. The median patient age was 64 years, and the median tumor volume was 2.2 cm(3). Overall, 19 metastases had been treated initially with RT. Of these, 16 had received stereotactic body RT and 3 had received whole brain RT. Three tumors were surgically excised and had received adjuvant stereotactic body RT in the upfront setting. Although 5 patients had presented with obstructive hydrocephalus, none had required CSF diversion. After treatment, 5 metastases had progressed, resulting in 1- and 3-year progression-free survival rates of 81.6% and 68%, respectively. The median overall survival was 2.8 years, with 1- and 5-year overall survival rates of 76.7% and 28.3%, respectively. Leptomeningeal carcinomatosis was not observed. CONCLUSIONS: Despite the relatively limited overall survival for this population with metastatic cancer, comparable to contemporary parenchymal brain metastasis cohorts, reasonable local central nervous system control was achieved in most patients using a paradigm of focal RT and resection, where indicated. Finally, CSF diversion was not required even in patients presenting with hydrocephalus.
引用
收藏
页码:E7 / E13
页数:7
相关论文
共 50 条
  • [41] Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
    Santoni, Matteo
    Conti, Alessandro
    Procopio, Giuseppe
    Porta, Camillo
    Ibrahim, Toni
    Barni, Sandro
    Guida, Francesco Maria
    Fontana, Andrea
    Berruti, Alfredo
    Berardi, Rossana
    Massari, Francesco
    Vincenzi, Bruno
    Ortega, Cinzia
    Ottaviani, Davide
    Carteni, Giacomo
    Lanzetta, Gaetano
    De Lisi, Delia
    Silvestris, Nicola
    Satolli, Maria Antonietta
    Collova, Elena
    Russo, Antonio
    Badalamenti, Giuseppe
    Fedeli, Stefano Luzi
    Tanca, Francesca Maria
    Adamo, Vincenzo
    Maiello, Evaristo
    Sabbatini, Roberto
    Felici, Alessandra
    Cinieri, Saverio
    Montironi, Rodolfo
    Bracarda, Sergio
    Tonini, Giuseppe
    Cascinu, Stefano
    Santini, Daniele
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 34
  • [42] Impact of Bone and Liver Metastases on Patients with Renal Cell Carcinoma Treated with Targeted Therapy
    Mckay, Rana R.
    Kroeger, Nils
    Xie, Wanling
    Lee, Jae-Lyun
    Knox, Jennifer J.
    Bjarnason, Georg A.
    MacKenzie, Mary J.
    Wood, Lori
    Srinivas, Sandy
    Vaishampayan, Ulka N.
    Rha, Sun-Young
    Pal, Sumanta K.
    Donskov, Frede
    Tantravahi, Srinivas K.
    Rini, Brian I.
    Heng, Daniel Y. C.
    Choueiri, Toni K.
    EUROPEAN UROLOGY, 2014, 65 (03) : 577 - 584
  • [43] Surgery and survival outcomes of 30 patients with neurological deficit due to clear cell renal cell carcinoma spinal metastases
    Han, Shuai
    Wang, Ting
    Jiang, Dongjie
    Yu, Yang
    Wang, Yu
    Yan, Wangjun
    Xu, Wei
    Cheng, Ming
    Zhou, Wang
    Xiao, Jianru
    EUROPEAN SPINE JOURNAL, 2015, 24 (08) : 1786 - 1791
  • [44] Use of ifosfamide, carboplatin, and etoposide chemotherapy in choroid plexus carcinoma Clinical article
    Lafay-Cousin, Lucie
    Mabbott, Donald J.
    Halliday, William
    Taylor, Michael D.
    Tabori, Uri
    Kamaly-Asl, Ian D.
    Kulkarni, Abhaya V.
    Bartels, Ute
    Greenberg, Mark
    Bouffet, Eric
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2010, 5 (06) : 615 - 621
  • [45] Clinical predictive factor of metastases in renal cell carcinoma
    Widia, F.
    Hamid, A. R. A. H.
    Mochtar, C. A.
    Umbas, R.
    BJU INTERNATIONAL, 2016, 117 : 9 - 10
  • [46] Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era
    Kalra, Sarathi
    Verma, Jonathan
    Atkinson, Bradley J.
    Matin, Surena F.
    Wood, Christopher G.
    Karam, Jose A.
    Lin, Sue-Hwa
    Satcher, Robert L.
    Tamboli, Pheroze
    Sircar, Kanishka
    Rao, Priya
    Corn, Paul G.
    Tannir, Nizar M.
    Jonasch, Eric
    CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : 363 - 370
  • [47] Characteristics and clinical outcomes of renal cell carcinoma in children: A single center experience
    Baek, Minki
    Jung, Jae Yong
    Kim, Jung Jun
    Park, Kwan Hyun
    Ryu, Dong Soo
    INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 (08) : 737 - 740
  • [48] Extracerebral metastases determine the outcome of patients with brain metastases from renal cell carcinoma
    Vogl, Ursula M.
    Bojic, Marija
    Lamm, Wolfgang
    Frischer, Josa M.
    Pichelmayer, Oskar
    Kramer, Gero
    Haitel, Andrea
    Kitz, Klaus
    Harmankaya, Kaan
    Zielinski, Christoph C.
    Schmidinger, Manuela
    BMC CANCER, 2010, 10
  • [49] Improving outcomes in patients with advanced renal cell carcinoma
    Sosman, Jeffrey A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (03) : 481 - 490
  • [50] The role of immunotherapy in the management of patients with renal cell carcinoma and brain metastases
    Fallah, Jaleh
    Ahluwalia, Manmeet S.
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7